🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Placebo to elinzanetant

Found 10 matching trials

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

PHASE3

Researchers are looking for a better way to treat women who have hot flashe...

Status

Completed

Location

Alabama Clinical Therapeutics | Birmingham, AL

Start Date

2021-08-27

Trial ID

NCT05042362

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

PHASE1

Researchers are looking for a better way to treat vasomotor symptoms (VMS),...

Status

Completed

Location

AltaSciences

Start Date

2024-01-08

Trial ID

NCT06219902

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo to elinzanetant Zopiclone Placebo to zopiclone

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

PHASE3

Researchers are looking for a better way to treat women with, or at high ri...

Status

Active Not Recruiting

Location

AKH Wien | Allg. Gynaekologie & gynaekologische Onkologie

Start Date

2022-10-14

Trial ID

NCT05587296

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

PHASE1

Researchers are looking for a better way to treat vasomotor symptoms, a con...

Status

Completed

Location

NUVISAN GmbH Neu-Ulm

Start Date

2022-08-19

Trial ID

NCT05481528

Treatments Being Tested

Moxifloxacin Elinzanetant (BAY3427080)Placebo

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

PHASE3

Researchers are looking for a better way to treat women who have hot flashe...

Status

Completed

Location

Mobile ObGyn, P.C. | Mobile, AL

Start Date

2021-08-27

Trial ID

NCT05030584

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2)

PHASE3

Researchers are looking for a better way to treat women who have hot flashe...

Status

Completed

Location

Accel Research Sites | Cahaba Medical Care - Birmingham, AL

Start Date

2021-10-29

Trial ID

NCT05099159

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study to Learn More About How the Study Treatment Elinzanetant (or BAY3427080) Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body After Taking Single and Multiple Doses in Healthy Women Aged 40 to 65 Years

PHASE1

Researchers are looking for a better way to treat men and women with vasomo...

Status

Completed

Location

The First Affiliated Hospital of Guangzhou University of TCM

Start Date

2022-05-23

Trial ID

NCT05381142

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

PHASE2

The purpose of this study is to determine the effectiveness of BAY3427080 (...

Status

Completed

Location

Study Site 12

Start Date

2018-11-20

Trial ID

NCT03596762

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause

PHASE2

Researchers are looking for a better way to treat women who have sleep dist...

Status

Completed

Location

Preferred Research Partners

Start Date

2023-11-08

Trial ID

NCT06112756

Treatments Being Tested

Elinzanetant Placebo

A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

PHASE1

Researchers are looking for a new way to treat women who have symptoms that...

Status

Completed

Location

SOUSEIKAI Fukuoka Mirai Hospital

Start Date

2021-08-11

Trial ID

NCT04981431

Treatments Being Tested

Elinzanetant (BAY3427080)Placebo

Previous Next